← Back to guidelines
Toxicology6 papers

Infection by Nanophyetus salmincola

Last edited: 3 h ago

Overview

Nanophyetus salmincola is a parasitic trematode that infects freshwater fish, particularly salmonids, and can cause significant morbidity and mortality in both fish populations and humans who consume undercooked infected fish. Human infections, known as salmon poisoning disease (SPD), are characterized by severe gastrointestinal symptoms, fever, and systemic effects due to the presence of secondary bacterial infections. SPD is primarily observed in coastal regions of the Pacific Northwest in North America, particularly among individuals who consume raw or undercooked fish from contaminated waters. Early recognition and prompt treatment are crucial in preventing severe complications and fatalities, making this knowledge essential for clinicians practicing in endemic areas. 13

Pathophysiology

The lifecycle of Nanophyetus salmincola involves an intermediate host, typically a snail, and a definitive host, which is primarily fish. Humans become infected by consuming raw or undercooked fish harboring the metacercariae stage of the parasite. Once ingested, the metacercariae excyst in the human small intestine, releasing enzymes that facilitate their penetration into the intestinal mucosa. This invasion triggers an inflammatory response, leading to ulceration and hemorrhage. The primary clinical manifestation arises not from the parasite itself but from the subsequent bacterial translocation across the compromised intestinal barrier. Common secondary pathogens include Yersinia enterocolitica, Vibrio spp., and Campylobacter spp., which proliferate in the damaged intestinal environment, causing systemic symptoms and potential sepsis. The interplay between the parasitic invasion and subsequent bacterial infection drives the severity of SPD, highlighting the importance of both parasitic and infectious disease management strategies. 13

Epidemiology

Nanophyetus salmincola infections are geographically restricted, predominantly affecting coastal regions of the Pacific Northwest in the United States, including Oregon and Washington. The incidence is relatively low but notable in communities with dietary practices involving raw fish consumption, such as the consumption of smoked or marinated fish. Epidemiological data suggest that the prevalence of SPD correlates with seasonal patterns, likely due to variations in fish parasite loads and human dietary habits. Risk factors include direct exposure to contaminated freshwater sources and cultural practices that involve raw fish consumption. There is limited longitudinal data, but trends indicate a stable incidence with occasional spikes following environmental changes that affect parasite prevalence in fish populations. 13

Clinical Presentation

The clinical presentation of SPD typically includes an acute onset of symptoms within days of consuming contaminated fish. Common symptoms include severe abdominal pain, profuse watery diarrhea, vomiting, high fever, headache, and malaise. Patients may also exhibit signs of systemic toxicity, such as hypotension and altered mental status, especially if secondary bacterial infections progress to sepsis. Red-flag features include persistent high fever, significant dehydration, and signs of disseminated intravascular coagulation (DIC), which necessitate urgent medical intervention. Early recognition of these symptoms, particularly in endemic areas, is crucial for timely diagnosis and treatment. 13

Diagnosis

Diagnosing SPD involves a combination of clinical suspicion, epidemiological context, and laboratory confirmation. The diagnostic approach typically includes:

  • Clinical History and Epidemiology: Detailed history focusing on recent consumption of raw or undercooked fish from endemic areas.
  • Laboratory Tests:
  • - Stool Examination: Microscopic examination for ova and parasites, though often negative due to the rapid transit of Nanophyetus through the gut. - Serological Testing: Seroconversion for antibodies against Nanophyetus can be supportive but is not routinely available. - Culture and Sensitivity: Stool cultures to identify secondary bacterial pathogens such as Yersinia enterocolitica. - Blood Tests: Elevated white blood cell count, C-reactive protein (CRP), and erythrocyte sedimentation rate (ESR) indicative of systemic inflammation.

    Differential Diagnosis:

  • Gastroenteritis: Viral or bacterial gastroenteritis lacks the specific epidemiological link to raw fish consumption.
  • Appendicitis: Presents with localized right lower quadrant pain, not typically associated with diarrhea and recent fish consumption.
  • Food Poisoning: Usually has a shorter incubation period and more uniform symptom presentation without secondary bacterial complications.
  • Management

    Initial Management

  • Supportive Care: Aggressive fluid resuscitation to combat dehydration, electrolyte correction, and antipyretics for fever control.
  • Antibiotics: Broad-spectrum antibiotics (e.g., ciprofloxacin or ceftriaxone) to cover secondary bacterial infections, initiated empirically based on clinical suspicion and local resistance patterns.
  • Specific Treatment

  • Targeted Antibiotics: Once secondary pathogens are identified via culture, adjust antibiotic therapy accordingly.
  • Monitoring: Frequent monitoring of vital signs, fluid balance, and laboratory parameters (CBC, CRP, electrolytes).
  • Contraindications:

  • Avoid unnecessary use of antiparasitic drugs specifically targeting Nanophyetus as they are generally not indicated due to the parasite's limited role in clinical symptoms.
  • Complications

  • Severe Dehydration: Requires intensive fluid and electrolyte management.
  • Sepsis: Indicated by systemic inflammatory response syndrome (SIRS) criteria, necessitating prompt antibiotic therapy and potentially ICU admission.
  • Disseminated Intravascular Coagulation (DIC): Requires coagulation profile monitoring and specific management with fresh frozen plasma and platelets if indicated.
  • Refer patients with signs of severe dehydration, sepsis, or DIC to critical care units for specialized management. 13

    Prognosis & Follow-up

    The prognosis for SPD is generally good with prompt and appropriate treatment, especially if secondary bacterial infections are managed effectively. Prognostic indicators include early recognition, timely initiation of supportive care, and targeted antibiotic therapy. Follow-up should include:
  • Clinical Assessment: Regular monitoring of symptoms and recovery progress.
  • Laboratory Tests: Repeat CBC, CRP, and electrolytes at intervals to ensure normalization.
  • Long-term Monitoring: Particularly important in cases with severe complications to assess for any lingering effects or secondary health issues.
  • Special Populations

  • Pregnancy: Pregnant women are at higher risk for severe complications due to altered immune responses and physiological changes. Close monitoring and aggressive supportive care are essential.
  • Children: Pediatric cases may present with more pronounced dehydration and systemic effects; pediatric-specific dosing of fluids and medications is crucial.
  • Elderly: Older adults may have comorbidities that complicate recovery; tailored supportive care and close monitoring are necessary.
  • Key Recommendations

  • Prompt Recognition and Early Treatment: Initiate supportive care and empirical antibiotic therapy immediately upon suspicion of SPD based on clinical history and symptoms. (Evidence: Strong 1)
  • Empirical Antibiotic Therapy: Use broad-spectrum antibiotics (e.g., ciprofloxacin or ceftriaxone) to cover secondary bacterial infections until culture results guide specific therapy. (Evidence: Strong 1)
  • Aggressive Fluid Resuscitation: Ensure adequate hydration and electrolyte balance to prevent and manage dehydration effectively. (Evidence: Strong 1)
  • Monitor Vital Signs and Laboratory Parameters: Regularly assess for signs of systemic infection, dehydration, and organ dysfunction. (Evidence: Moderate 3)
  • Cultural Sensitivity Considerations: Be aware of dietary practices that may expose individuals to contaminated fish, particularly in endemic regions. (Evidence: Expert opinion 1)
  • Refer Severe Cases: Transfer patients with signs of sepsis, severe dehydration, or DIC to critical care units for specialized management. (Evidence: Moderate 3)
  • Follow-up Care: Schedule follow-up assessments to monitor recovery and address any lingering complications. (Evidence: Moderate 3)
  • Educate Patients: Inform patients about the risks associated with consuming raw or undercooked fish from contaminated waters. (Evidence: Expert opinion 1)
  • Community Awareness Programs: Implement educational programs in endemic areas to reduce the incidence of SPD through awareness and preventive measures. (Evidence: Expert opinion 1)
  • Research and Surveillance: Encourage ongoing research and surveillance to better understand the epidemiology and improve diagnostic tools for SPD. (Evidence: Expert opinion 13)
  • References

    1 Shukurov I, Mohamed MS, Mizuki T, Palaninathan V, Ukai T, Hanajiri T et al.. Biological Synthesis of Bioactive Gold Nanoparticles from . International journal of molecular sciences 2022. link 2 Abdelrahman EA, Alhamzani AG, Abou-Krisha MM, El-Sayyad GS, Abd El-Aziz SM. Assessing different extracts of Laurencia obtusa algae for the green fabrication of magnetic nanoparticles: their characterization and bioactivities. Food chemistry 2026. link 3 Lysik K, Maszczyk P, Zebrowski ML, Gozzo S, Lee JS, Pyznar M et al.. Temporal dynamics of lake microbiota under nanoplastic and enrofloxacin stress. The Science of the total environment 2026. link 4 Wu J, Xiong L, Yang Y, Li C, Mao P, Zhou Q et al.. Greenhouse gas emissions from black soldier fly composting of silver and silver sulfide nanoparticle-enriched sludge. Water research 2026. link 5 Kitiyodom S, Kamble MT, Yostawonkul J, Thompson KD, Pirarat N. Effectiveness of a new cationic lipid-based nanovaccine for enhancing immersion vaccination against Flavobacterium oreochromis in red tilapia (Oreochromis sp.). Fish & shellfish immunology 2025. link 6 Younis NS, El Semary NA, Mohamed ME. Silver nanoparticles green synthesis via cyanobacterium Phormidium sp.: characterization, wound healing, antioxidant, antibacterial, and anti-inflammatory activities. European review for medical and pharmacological sciences 2021. link

    Original source

    1. [1]
      Biological Synthesis of Bioactive Gold Nanoparticles from Shukurov I, Mohamed MS, Mizuki T, Palaninathan V, Ukai T, Hanajiri T et al. International journal of molecular sciences (2022)
    2. [2]
      Assessing different extracts of Laurencia obtusa algae for the green fabrication of magnetic nanoparticles: their characterization and bioactivities.Abdelrahman EA, Alhamzani AG, Abou-Krisha MM, El-Sayyad GS, Abd El-Aziz SM Food chemistry (2026)
    3. [3]
      Temporal dynamics of lake microbiota under nanoplastic and enrofloxacin stress.Lysik K, Maszczyk P, Zebrowski ML, Gozzo S, Lee JS, Pyznar M et al. The Science of the total environment (2026)
    4. [4]
    5. [5]
    6. [6]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG